Influence of antineoplastic drugs on morphine analgesia and on morphine tolerance

European Journal of Pharmacology

Volumn 367, Issue 1, 1999, Pages 13-17

  Genedani, Susanna ^a   Bernardi, M ^a   Bertolini, A ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

(Mouse); Adriamycin; Analgesia; Antineoplastic drug; Cisplatin; Methotrexate; Morphine; Pain; Tolerance; Vincristine

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; METHOTREXATE; MORPHINE; NARCOTIC ANALGESIC AGENT; VINCRISTINE;

ANALGESIA; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HOT PLATE TEST; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MORPHINE TOLERANCE; MOUSE; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANALGESICS, OPIOID; ANIMALS; ANTINEOPLASTIC AGENTS; CISPLATIN; DOXORUBICIN; DRUG TOLERANCE; HEAT; MALE; METHOTREXATE; MICE; MORPHINE; PAIN THRESHOLD; VINCRISTINE;

EID: 0032966490     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00966-2     Document Type: Article

References (25)

1. Adamson R.H., Dixon R.L., Ben M., Crews L., Shohet S.B., Rall D.P. Some pharmacologic properties of vincristine. Arch. Int. Pharmacodyn. 157:1965;299-311.
2. Arena E., d'Alessandro N., Dusonchet L., Gebbia N., Gerbasi F., Palazzoadriano M., Raineri A., Rausa L., Tubaro E. Analysis of the pharmacokinetic characteristics, pharmacological and chemotherapeutic activity of 14-hydroxy-daunomycin (adriamycin), a new drug endowed with an antitumour activity. Arzneim. Forsch. 21:1971;1258-1263.
3. Bertino J.R., Sawicki W.L., Lindquist C.A., Gupta V.S. Schedule-dependent antitumor effects of methotrexate and 5-fluorouracil. Cancer Res. 37:1977;327-328.
4. Busnhell T.G., Justin D.M. Choosing the right analgesic. A guide to selection. Drugs. 46:1993;394-408.
5. Chabner, B.A., Allegra, C.J., Curt, G.A., Calabresi, P., 1996. Antineoplastic agents. In: Goodman Gilman, A., Hardman, J.G., Limbird, L.E., Molinoff, P.B., Ruddon, R.W. (Eds.), The Pharmacological Basis of Therapeutics, 9th edn. McGraw-Hill, New York, pp. 1195-1246.
6. Cherny N.I. Opioid analgesics. Comparative features and prescribing guidelines. Drugs. 51:1996;713-737.
7. Cohen M., Keats A.S., Krivoy W., Ungar G. Effect of actinomycin D on morphine tolerance. P.S.E.B.M. 119:1965;381-384.
8. Dickenson A.H. Mechanisms of the analgesic actions of opiates and opioids. Br. Med. Bull. 47:1991;690-702.
9. Eastman A. Characterization of the adducts produced in DNA by cis-diaminedichloroplatinum (II) and cis-dichloro-(ethylenediamine) platinum (II). Biochemistry. 22:1983;3927-3933.
10. Eastman A. Intrastrand cross-links and sequence specificity in the reaction of cis-dichloro (ethylene-diamine) platinum (II) with DNA. Biochemistry. 24:1985;5027-5032.
11. Eddy N.N., Leimbach D. Synthetic analgesics: II. Dithienyl-butenyl and dithienylbutylamines. J. Pharmacol. Exp. Ther. 107:1953;385-388.
12. Elwood P.C. Molecular cloning and characterization of the human folate binding protein cDNA from placenta and malignant tissue culture (KB) cells. J. Biol. Chem. 264:1989;14893-14901.
13. Hsiang Y.H., Wu H.Y., Liu L.F. Topoisomerases: novel therapeutic targets in cancer chemotherapy. Biochem. Pharmacol. 37:1988;1801-1802.
14. 10-methyl-5,6,7,8-tetrahydropteroylglutamic acid (tetrahydroamethopterin). Nature. 189:1961;937-939.
15. Myers C.E., McGuire W.P., Liss R.H., Ifrim I., Grotzinger K., Young R.C. Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response. Science. 197:1977;165-167.
16. Nahabedian M.Y., Cohen R.A., Contino M.F., Terem T.M., Wright W.H., Berns M.W., Wile A.G. Combination cytotoxic chemotherapy with cisplatin or doxorubicin and photodynamic therapy in murine tumors. J. Nat. Cancer Inst. 80:1988;739-743.
17. Reed E., Yupsa S.H., Zwelling L.A., Ozols R.F., Poirier M.C. Quantitation of cis-diaminedichloroplatinum II (cisplatin)-DNA-intrastrand adducts in testicular and ovarian cancer patients receiving cisplatin chemotherapy. J. Clin. Invest. 77:1986;545-550.
18. Rosenberg B., VanCamp L. The successful regression of large solid sarcoma 180 tumors by platinum compounds. Cancer Res. 30:1970;1799-1802.
19. Rosenberg B., VanCamp L., Trosko J.E., Mansour V.H. Platinum compounds: a new class of potent antitumor agents. Nature. 222:1969;385-386.
20. Sobell H.M. The stereochemistry of actinomycin binding to DNA and its implications in molecular biology. Prog. Nucleic Acid Res. Mol. Biol. 13:1973;153-190.
21. Thurlimann B., Stoutz N.D. Causes and treatment of bone pain of malignant origin. Drugs. 51:1996;383-398.
22. Tritton T.R., Murphree S.A., Sartorelli A.C. Adriamycin: a proposal on the specificity of drug action. Biochem. Biophys. Res. Commun. 84:1978;802-808.
23. Trujllo K.A., Akil H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science. 251:1991;85-87.
24. Woolfe G., MacDonald A. The evaluation of the analgesic action of pethidine hydrochloride (Demerol). J. Pharmacol. Exp. Ther. 80:1944;300-305.
25. World Health Organization, 1990. Cancer pain relief and palliative care: report of a WHO Expert Committee. WHO Technical Report Series, No. 804. Geneva.